Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Trupti Pai"'
Autor:
Prerana Jha, Vaishakhi Trivedi, Nandini Menon, Minit Shah, Irene A George, Rohit Mishra, Trupti Pai, Fuzail Ahmad, Venkataramanan Ramachandran, Vanita Noronha, Kumar Prabhash, Prashant Kumar
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 7, Iss 1, Pp 110-116 (2024)
Externí odkaz:
https://doaj.org/article/5ffbb472eed9486e93eefda84451a7d3
Autor:
Anuradha Chougule, PhD, Pratik Chandrani, PhD, Vanita Noronha, MD, DM, Priyanka Pange, BSc, Shrutikaa Kale, MSc, Ankita Nikam, MSc, Kavya Nambiar, MSc, Dipika Marchande, BSc, Arpana Durve, BSc, Vinod Gupta, BSc, Vinita Jagtap, MSc, Priyanka Tiwrekar, BA, Nandini Menon, MD, DM, Amit Joshi, MD, DM, Rajeev Kaushal, MD, Trupti Pai, MD, Vijay Maruti Patil, MD, DM, Amit Dutt, PhD, Shripad Dinanath Banavali, MD, Kumar Prabhash, MD, DM
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 11, Pp 100566- (2023)
The significance of EGFR targeted therapy in the lung adenocarcinoma is paramount. Several controlled clinical trials have reported considerable survival of EGFR mutation positive patients on receiving the EGFR tyrosine kinase inhibitor (TKI). Howeve
Externí odkaz:
https://doaj.org/article/43043fa0334043ed8be10de1c26073d8
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 7, Iss 1, Pp 141-142 (2024)
Externí odkaz:
https://doaj.org/article/ac712984741a4621ae6eebd95bf16d2b
Autor:
Jaspreet Kaur, Ajaykumar Singh, Minit Shah, Pratik Chandrani, Anuradha Chougule, Omshree Shetty, Trupti Pai, Santosh Menon, Subhash Yadav, Akhil Kapoor, B K Mishra, Amit Dutt, Vanita Noronha, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 2, Pp 288-295 (2023)
Externí odkaz:
https://doaj.org/article/093ef49f2c804ba58a9659a46250ddff
Autor:
Minit Shah, Vanita Noronha, Omshree Shetty, Trupti Pai, Vijay Patil, Akhil Kapoor, Nandini Menon, Ajay K Singh, Pratik Chandrani, Anuradha Chougule, Rajeev Kumar Kaushal, Subhash Yadav, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 1, Pp 94-102 (2023)
Externí odkaz:
https://doaj.org/article/d4aba08155ed4c4eba8257e1e66e9f0a
Publikováno v:
Türk Patoloji Dergisi, Vol 38, Iss 2, Pp 162-166 (2022)
Low-grade Oncocytic Tumor (LOT) of kidney is an emerging neoplasm that forms an important differential diagnosis in a spectrum of entities with oncocytic morphology. It has overlapping features with renal oncocytoma and eosinophilic variant of chromo
Externí odkaz:
https://doaj.org/article/4846a8e7791b46a3a318ed8a4d2299fd
Autor:
Akhil Kapoor, MD, DM, Vanita Noronha, MD, DM, Vijay Patil, MD, DM, Nandini Menon, MD, DNB, Amit Joshi, MD, DM, Amit Kumar, MD, DM, Ajay Kumar Singh, MD, DM, Abhishek Mahajan, MD, Amit Janu, MD, Rajiv Kumar, MD, Trupti Pai, MD, Anuradha Chougule, MD, Omshree Shetty, MD, Kumar Prabhash, MD, DM, ECMO
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100443- (2023)
Introduction: ALK inhibitors are one of the success stories in precision medicine for treating patients with advanced ALK-positive NSCLC. Nevertheless, developing countries have substantial constraints in using ALK inhibitors, with limited data from
Externí odkaz:
https://doaj.org/article/93d145c0f2574e66b581ca7619604c26
Autor:
Vichitra Behel, Vanita Noronha, Anuradha Choughule, Omshree Shetty, Pratik Chandrani, Akhil Kapoor, Suresh Kumar Bondili, Jyoti Bajpai, Rajiv Kumar, Trupti Pai, Munita Bal, Mamta Gurav, Prachi Bapat, Neha Mittal, Santosh Menon, Vijay Patil, Nandini Menon, Amit Dutt, Kumar Prabhash
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEMultidisciplinary molecular tumor boards (MTBs) help in interpreting complex genomic data generated by molecular tumor profiling and improve patients' access to targeted therapies. The purpose of this study was to assess the impact of our inst
Externí odkaz:
https://doaj.org/article/409e38aa0e864a05a8592466f556a398
Autor:
Omshree Shetty, Tanuja Shet, Ramya Iyer, Prachi Gogte, Mamta Gurav, Pradnya Joshi, Nupur Karnik, Trupti Pai, Sridhar Epari, Sangeeta Desai
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274089 (2022)
BackgroundMolecular tests in solid tumours for targeted therapies call for the need to ensure precision testing. To accomplish this participation in the External Quality Assessment Program (EQAS) is required. This evaluates the consistency of diagnos
Externí odkaz:
https://doaj.org/article/29a034a755034959917d148d25ee834f
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 63, Iss 2, Pp 194-199 (2020)
Context: HER2/neu testing in breast cancer is a mandate due to availability of trastuzumab, a monoclonal antibody targeted against this biomarker. Dual-color dual-hapten in situ hybridization (D-DISH) is a new test for assessment of HER2/neu gene ove
Externí odkaz:
https://doaj.org/article/fc99d94423244bee9d05d1ea90872006